Motus GI Holdings, Inc.
MOTS Healthcare Medical Devices
Motus GI Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $319,000.00, down 46.1% from fiscal 2022. Operating cash flow growth for three consecutive years.
Follow MOTS
Motus GI Holdings, Inc. (MOTS) EV/Sales
As of 15 October 2026, Motus GI Holdings, Inc. (MOTS) trades at a EV/Sales of −8.1×. Over the past ten years it has ranged from −72.7× (March 2020) to 7,614× (December 2019); the current reading is higher than 24% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2023 | −5.1× | — |
| FY2022 | −0.2× | — |
| FY2021 | 27.5× | (85.19%) |
| FY2020 | 185× | (46.83%) |
| FY2019 | 349× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Mar 2024 | 3.5× | — |
| Dec 2023 | −5.1× | — |
| Sep 2023 | 22.1× | 93.19% |
| Jun 2023 | 11.4× | 11.90% |
| 20 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MOTS Motus GI Holdings, Inc. | −8.1× |
| PFSA PROFUSA, Inc. compare | n/m |
| NUWE Nuwellis, Inc. compare | 0.0× |
| FEED ENvue Medical, Inc. compare | 0.1× |
| DYNTQ Dynatronics Corporation compare | 0.1× |
| DHAI DIH Holding US, Inc. compare | 0.1× |
| SSKN Strata Skin Sciences, Inc. compare | 0.7× |
| THMO ThermoGenesis Holdings, Inc. compare | 0.8× |
| AFIB Acutus Medical, Inc. compare | 0.9× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)